Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments

Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of currently used drugs represent major barriers that need to be overcome to provide a viable cure. Nanomedicines (NMeds)...

Descripción completa

Detalles Bibliográficos
Autores principales: Duskey, Jason Thomas, Rinaldi, Arianna, Ottonelli, Ilaria, Caraffi, Riccardo, De Benedictis, Chiara Alessia, Sauer, Ann Katrin, Tosi, Giovanni, Vandelli, Maria Angela, Ruozi, Barbara, Grabrucker, Andreas Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325049/
https://www.ncbi.nlm.nih.gov/pubmed/35890345
http://dx.doi.org/10.3390/pharmaceutics14071450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325049/
https://www.ncbi.nlm.nih.gov/pubmed/35890345
http://dx.doi.org/10.3390/pharmaceutics14071450

Ejemplares similares